Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease

Circulation Research - United States
doi 10.1161/circresaha.114.302022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Mammalian Target of Rapamycin and Caspase Inhibitors in Polycystic Kidney Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2008English

Inflammation‐induced Mammalian Target of Rapamycin Signaling Is Essential for Retina Regeneration

GLIA
Molecular NeuroscienceNeurologyCellular
2019English

Aberrant Hyperactivation of Akt and Mammalian Target of Rapamycin Complex 1 Signaling in Sporadic Chordomas

Clinical Cancer Research
Cancer ResearchOncology
2009English

Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)

Science-Business eXchange
2010English

Mammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2016English

Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin

Clinical Cancer Research
Cancer ResearchOncology
2008English

Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2006English

Immunohistochemical Analysis of Phosphorylated Mammalian Target of Rapamycin and Its Downstream Signaling Components in Invasive Breast Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy